Menu Close

RNA BIOCHEMISTRY IS ONE OF THE MOST PROMISING AREAS OF MEDICINAL INNOVATION

First Health Pharmaceuticals has a leading position in the field of advanced RNA biochemistry. We aim to further develop our portfolio of highly active patented RNA Helicase inhibiting lead compounds and bring revolutionary pharmaceuticals to the market that will offer new hope for patients suffering from some of the most challenging diseases of our time.

HIV RESERVOIR REDUCTION

First Health Pharma developed the first ever generation of Translation Inhibitor compounds effective against HAART resistant HIV strains and is investigating potential strategies to be applied in a HIV Shock & Kill approach.

RNA TECHNOLOGY

The translation of RNA to proteins is fundamental for cell survival and replication, thus First Health Pharmaceuticals has set its RNA Research priorities on the development of RNA Helicase inhibiting lead compounds.

Cancer targets

DDX3 RNA helicase has remarkable oncogenic properties. It is overexpressed in the malignant types of Breast and Lung cancer. Our DDX3 inhibitors can be considered apoptosis-inducing targeted antitumor agents.

Our Current research projects

Visit our news section

Recent on social


#FirstHealthPharma is thrilled to announce the opening of its new #laboratory facilities in Colle di Val d’Elsa-Italy, equipped with proprietary state of the art instruments. https://t.co/vrHKMjb7tL
#RNAtechnology #DDX3 https://t.co/IKgF1d1R2A
FH_Pharma photo
First Health Pharmaceuticals
First Health Pharmaceuticals
First Health Pharmaceuticals is thrilled to announce the opening of its new laboratory facilities in Colle di Val d’Elsa – Italy, equipped with proprietary state of the art instruments (the latest spectrometers, advanced automated plate readers and cell counting equipment), which will also operate as a hub for its partners in the life sciences concentration around Siena.

#laboratory #RNAtechnology #DDX3 #antiviral #biotech #rnavirus #oncology #ADME #siena #LifeSciences

https://www.firsthealthpharma.com/new-laboratory-facilities-in-italy/

Leave a Reply